0000000000165835

AUTHOR

Girts Skenders

showing 5 related works from this author

Profiles of Volatile Biomarkers Detect Tuberculosis from Skin

2021

Abstract Tuberculosis (TB) is an infectious disease that threatens >10 million people annually. Despite advances in TB diagnostics, patients continue to receive an insufficient diagnosis as TB symptoms are not specific. Many existing biodiagnostic tests are slow, have low clinical performance, and can be unsuitable for resource‐limited settings. According to the World Health Organization (WHO), a rapid, sputum‐free, and cost‐effective triage test for real‐time detection of TB is urgently needed. This article reports on a new diagnostic pathway enabling a noninvasive, fast, and highly accurate way of detecting TB. The approach relies on TB‐specific volatile organic compounds (VOCs) that are …

Malepoint‐of‐care testdiagnosisGeneral Chemical EngineeringGeneral Physics and AstronomyMedicine (miscellaneous)02 engineering and technology01 natural sciencesSouth AfricasensorGeneral Materials ScienceResearch ArticlesQGeneral EngineeringClinical performanceMiddle Aged021001 nanoscience & nanotechnologytuberculosisFemale0210 nano-technologyPulmonary tbResearch ArticleAdultmedicine.medical_specialtyskinTuberculosisPoint-of-care testingScienceIndiawearable device010402 general chemistrySensitivity and SpecificityBiochemistry Genetics and Molecular Biology (miscellaneous)Gas Chromatography-Mass SpectrometryWorld healthYoung AdultmedicineHumansIntensive care medicineVolatile Organic Compoundsbusiness.industrynoninvasive approachReproducibility of Resultsmedicine.diseaseTriage0104 chemical sciencesInfectious disease (medical specialty)Test requirementsbusinessBiomarkersAdvanced Science
researchProduct

Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 y…

2020

Background According to recent estimates 80% of Latvian population is infected with Helicobacter pylori thus their susceptibility to numerous gastric tract diseases is increased. The 1st line H. pylori eradication therapy includes treatment with clarithromycin in combination with amoxicillin or metronidazole and a proton pump inhibitor. However, potential adverse events caused by such therapies to microbiome are insufficiently studied. Objective This study aimed to evaluate the long-term effect of H. pylori eradication on human gastrointestinal tract (GIT) microbiome. Methods The assessment of H pylori eradication impact on GIT microbiome was done by analyzing 120 samples acquired from 60 s…

AdultMalemedicine.medical_specialtyPopulationGastroenterologyHelicobacter Infections03 medical and health sciences0302 clinical medicineInternal medicineClarithromycinClarithromycinMetronidazolemedicineHumansMicrobiomeeducationeducation.field_of_studybiologybusiness.industryGastroenterologyAmoxicillinProton Pump InhibitorsGeneral MedicineHelicobacter pyloriAmoxicillinMiddle Agedbiology.organism_classificationLatviaAnti-Bacterial AgentsGastrointestinal MicrobiomeMetronidazoleInfectious Diseases030220 oncology & carcinogenesis030211 gastroenterology & hepatologyEnterotypeDrug Therapy CombinationFemaleSample collectionbusinessmedicine.drugHelicobacterREFERENCES
researchProduct

Generation of a novel next-generation sequencing-based method for the isolation of new human papillomavirus types

2018

Abstract With the advent of new molecular tools, the discovery of new papillomaviruses (PVs) has accelerated during the past decade, enabling the expansion of knowledge about the viral populations that inhabit the human body. Human PVs (HPVs) are etiologically linked to benign or malignant lesions of the skin and mucosa. The detection of HPV types can vary widely, depending mainly on the methodology and the quality of the biological sample. Next-generation sequencing is one of the most powerful tools, enabling the discovery of novel viruses in a wide range of biological material. Here, we report a novel protocol for the detection of known and unknown HPV types in human skin and oral gargle …

0301 basic medicineGenotypeComputational biologyBiologyOral cavityPolymerase Chain ReactionArticleDNA sequencinglaw.inventionCohort Studies03 medical and health scienceslawVirologyHumansProspective StudiesPapillomaviridaePapillomaviridaePolymerase chain reactionDNA PrimersSkinHuman papillomavirus typesMouthHpv typesPapillomavirus InfectionsHigh-Throughput Nucleotide SequencingSequence Analysis DNAIsolation (microbiology)biology.organism_classificationBiological materials030104 developmental biologyDNA ViralVirology
researchProduct

Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis.

2003

In order to characterise molecular mechanisms of first-line drug resistance in Mycobacterium tuberculosis and to evaluate the use of molecular markers of resistance (gene point mutations), we analysed 66 multi-drug-resistant (MDR) isolates from Latvian tuberculosis patients. They were all resistant to rifampin (RIF), isoniazid (INH) and streptomycin (SM), and 33 were resistant to ethambutol (EMB). Enzymatic digestion by MboII and nucleotide sequencing of the rpsL gene fragment detected a single nucleotide substitution K43R in 40 (61%) of the 66 SM-resistant M. tuberculosis isolates. Of the other 26 SM-resistant isolates, 16 (24%) had mutations at positions 513A--C and 516C--T of the rrs gen…

DNA BacterialRibosomal ProteinsDrug resistanceGene mutationMicrobiologyPolymerase Chain ReactionMycobacterium tuberculosisAnti-Infective AgentsDrug Resistance Multiple BacterialRNA Ribosomal 16SmedicineHumansTuberculosisDeoxyribonucleases Type II Site-SpecificMolecular BiologyEthambutolPolymorphism Single-Stranded ConformationalAntibacterial agentGeneticsbiologyPoint mutationSingle-strand conformation polymorphismGeneral MedicineMycobacterium tuberculosisSequence Analysis DNAbiology.organism_classificationMolecular biologyStreptomycinStreptomycinEthambutolmedicine.drugResearch in microbiology
researchProduct

Spectrum of pncA Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates Obtained in Latvia

2004

Pyrazinamide (PZA) is an effective antituberculous agent ([1][1]) that becomes active when bacterial pyrazinamidase converts it to pyrazinoic acid, which is toxic to mycobacteria ([4][2]). In Mycobacerium tuberculosis , PZA resistance is associated with the loss of pyrazinamidase activity, mainly

TuberculosisAntitubercular AgentsAmidohydrolasesMicrobiologyMycobacterium tuberculosischemistry.chemical_compoundPyrazinoic acidDrug Resistance Multiple BacterialmedicineHumansTuberculosisPharmacology (medical)Multidrug-Resistant Mycobacterium tuberculosisCodonLetters to the EditorPharmacologybiologyReverse Transcriptase Polymerase Chain ReactionMycobacterium tuberculosisPyrazinamidebiology.organism_classificationmedicine.diseaseLatviaPyrazinamideVirologyInfectious DiseaseschemistryMutationPncAmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct